The Treatment of Poliomyelitis and Other Virus Diseases
with Vitamin C (1)
A guest document by Fred R. Klenner, M.D., Reidsville, North Carolina - July 1949
with Vitamin C (1)
A guest document by Fred R. Klenner, M.D., Reidsville, North Carolina - July 1949
Note: For a shorter reading, you can jump to "60 cases of poliomyelitis under our care; Vitamin C in massive doses"
IN A PREVIOUS REPORT dealing with the antagonistic properties of ascorbic acid to the virus of atypical pneumonia, mention was made of the fact that other types of virus infections had responded favorably to vitamin C. This paper is to present these findings as well as the results of subsequent studies on the virus of poliomyelitis, the viruses causing measles, mumps, chickenpox, herpes zoster, herpes simplex and influenza. Further studies with the virus of atypical pneumonia will also be discussed.
These observations of the action of ascorbic acid on virus diseases were made independently of any knowledge of previous studies using vitamin C on virus pathology, except for the negative report of Sabin after treating Rhesus monkeys experimentally infected with the poliomyelitis virus. A review of the literature in preparation of this paper, however, presented an almost unbelievable record of such studies. The years of labor in animal experimentations, the cost in human effort and in "grants," and the volumes written, make it difficult to understand how so many investigators could have failed in comprehending the one thing that would have given positive results a decade ago. This one thing was the size of the dose of vitamin C employed and the frequency of its administration. In all fairness it must be said that Jungeblut noted on several occasions that he attributed his failure of results to the possibility that the strength of his injectable "C" was inadequate. It was he who unequivocally said that ''vitamin C can truthfully be designated as the antitoxic and antiviral vitamin."
In developing this paper it was felt that, since all virus infections were more or less akin, only one of this family would be considered in detail. Poliomyelitis, because of its prevalence and the seriousness of the problem it presents, was chosen as the disease to be so treated.
Poliomyelitis is in most instances an acute febrile disease of sudden onset, with symptoms of a systemic infection which either abruptly abort or develop to hyperesthesia, asymmetry of reflexes and flaccid paralysis or palsies of muscle groups. It affects individuals of all ages, but mainly children, as do more common childhood diseases to which class it most likely belongs. Only slight contact between the carrier of the virus and the susceptible person suffices in some cases for the transfer of the causative organism. In this respect and also in that the virus can be demonstrated in the nasal washings as early as six days before onset of symptoms, poliomyelitis resembles measles.
We never have an epidemic of poliomyelitis preceding an epidemic of measles; the opposite is frequently true. This grouping of the virus organisms is too often repeated not to carry some significance. For example, atypical pneumonia and influenza are caused by closely allied viruses; so are chickenpox, herpes zoster and herpes simplex; so are measles, mumps and poliomyelitis. The incubation period depends on the mode of entry. In experimental animals. Fraser and others showed that the average was 6.6 days with intracerebral inoculation and ten days when the intravenous route was used. Howitt mentions that the virus reaches the nervous system sooner after intranasal than after intravenous instillations. Transmission (Brodie, 1934) is by means of droplets from the mucous membrane of the upper respiratory tract. Infection by means of raw milk, human feces and house flies is highly improbable.
Poliomyelitis as a disease of the entire nervous system
The research of Flexner, dark and Amoss in 1914 proved that poliomyelitis is a disease of the entire nervous system, that the sensory ganglia are the seats of early and profound histological changes. The disease is significant mainly for the paralysis produced through injury to the motor neurons of the spinal cord and brain. This is caused by a special affinity of the virus for a certain type of nerve tissue. Experiments show the cerebral cortex to be the most unsatisfactory site for growth, that large amounts of the virus placed in this area are apt to disappear in a short time. Observations in monkeys and in man show that the anterior horn cells, particularly those of the lumbar cord, are the most favorable sites for proliferation of the virus.
Invasion by several channels
In all clinically ill patients the virus eventually travels in the course of its invasion by several channels. The virus can make a direct assault through the olfactory bulb, to the brain, medulla and spinal cord. The virus can enter the blood stream directly or through the lymph channels. Following damage to the natural protective barrier, the choroid plexus, it can make its way to the central nervous system, or it can be excreted back onto the nasal mucous membrane where it will pick up the direct route of the olfactory bulb.
The direct route to the brain
Clark, Turner and Reynolds (1926, 1927, 1929) concluded that the virus chiefly travels by the direct route to the brain. Lennette and Hudson ( 1935) confirmed this theory and reported their studies indicating that human infection is chiefly through the nasopharynx. Brodi and others showed that by section of the olfactory tracts in monkeys infection by the direct route was prevented. It is of more than mere academic interest that while the nasal mucosa of the monkey contains branches of the 5th and 7th cranial nerves and that in addition, since the virus can readily gravitate from the nasopharynx to the tonsil bed with its nerve supply, if the olfactory tracts are cut no infection will occur. The most likely explanation is that the olfactory is non-medullated, the neurons lie in the nasal mucosa and are thus exposed to the virus. The sciatic nerve (Brodi) will transport the virus only when it has been injured, suggesting that lack of myelin may render the healthy olfactory nerve vulnerable to the virus.
Secondary routes: blood and nasal mucosa
The most important of the secondary routes of infection is by the excretion of the virus from the blood stream onto the nasal mucosa. Lennette and Hudson (1934, 1935) demonstrated in monkeys that by sectioning the olfactory tracts and then inoculating by the intravenous route with the virus of poliomyelitis, they could prevent infection.
This would fit in with the work of Jungeblut and others that the spread of the virus through the central nervous system is along nerve tracts, rather than by means of the cerebrospinal fluid, the infection to become manifest when the first cell group is reached, and by relays of fibers, reaches the mid-brain. Here numerous fiber-paths run in all directions and the virus is carried by both motor and sensory axons, causing disease at many levels of the brain and cord.
Since there is always a period of septicemia in the first few days of poliomyelitis, it might be that this is the all-important route and that the virus is grown on a living tissue, the blood, and then is deposited out on the surface of the olfactory bulb. From this we conclude that the time to destroy the virus is during this incubation period which varies more with virulence and power of multiplication than with size of initial dose.
Through the choroid plexus
The second flanking maneuver of importance is through the choroid plexus. It is the function of the choroid plexus and the pial lymphatic vessels to exclude the virus present in the blood from the nervous system. Once these protective structures are injured, however, the exclusion ceases and infection can follow readily. Changes in the structure or function of the meningeal choroid plexus complex, too slight to be detected in the cerebro-spinal fluid or as morphological alterations, materially diminish its protective power. Flexner and Amoss injected large doses of the virus intravenously, then tested the cerebrospinal fluid and found no virus after the first 48 hours; virus in small amounts at the end of 72 hours; after 96 hours evidence of free access to this system. The virus was still present 19 days later when paralysis was beginning.
Poliomyelitis in man is always more severe if exercise is taken at time of the infection. Here one must consider the factor of filtration of the virus through the choroid plexus as being increased due to the elevation of the vascular bed pressure. Also, that, by the acceleration of the blood flow caused by greater oxygen demand in physical effort, a marked increase in the percentage of the virus deposited on the nasal mucosa would result.
We must agree with Fairbrother and Hurst that too little consideration has been given to the pathology of the nervous system and in particular to the drainage of the tissue fluids. These men confirmed the earlier work of Schroder, who stressed that the normal flow of these fluids is along the perivascular spaces from the center of the cord outward, and that any inflammatory exudate occupying these spaces must be swept into the pial meshes; further that meningeal infiltration may seem nothing more than a drainage of cells from the interior of the cord. Fairbrother and Hurst found that meningeal infiltration does not occur in monkeys until the perivascular infiltration beginning in the deeper vessels reaches the surface.
The mucous membrane
The presence of the filterable microorganism or virus of poliomyelitis upon the mucous membrane of the nose and throat does not necessarily lead to infection. It may give rise to a class of healthy carriers who are themselves immune. Amoss and Taylor found a secretion of the mucous membrane capable of neutralizing or inactivating the virus, this property absent altogether from the secretions of some persons, in those of others present at one time and not at another. It is probable that in actively immune animals the passage of the neutralizing substance from the blood into the cerebrospinal fluid would continue as long as the inflammation present in the meninges rendered the structures easily permeable to the protein constituents of the blood. This secretion X could not have the properties of a true antibody. The virus of poliomyelitis is intracellular from the time it invades the terminal cells of the olfactory system until the end of the disease, except when crossing the synaptic junctions between cells. This explains why the virus cannot be neutralized by antibodies in the serum. Further protection is afforded the virus by the functional barrier between the circulating blood and the central nervous system.
Sabin's negative report
Since immunization against poliomyelitis comparable to that against other bacterial diseases is still a matter of the future, it suggested itself that some antibiotic could be found that would destroy this scourge while in the phase of blood-stream invasion. Sabin's negative report on the value of ascorbic acid on the poliomyelitis virus stopped Jungeblut's work, but we were cognizant of its dramatic effect on the virus causing atypical pneumonia, and so kept up hope. These results were so consistently positive that we did not hesitate to try its effectiveness against all type of virus infections. The frequent administration of massive doses of vitamin C was so encouraging in the early days of the 1948 epidemic of poliomyelitis that a review of the literature was begun.
Heaslip, in the Australian Journal of Experimental Biology & Medicine reported a mean urinary output of vitamin C under a load test of 19.9 per cent in 60 poliomyelitis cases, as contrasted with a mean figure of 44.3 per cent in 45 healthy contacts. This was suggestive of some relationship between the degree of vitamin C saturation and the infectious and non-infectious state. He was also able to show a correlation between the severity of the attack and the level of urinary excretion of the vitamin. This would indicate that a deficiency of vitamin C in the diet predisposed to infection and to severity of attack. Sabin reported no appreciable difference in infectivity of poliomyelitis in monkeys with much or no vitamin C in the diet.
Many others, however, have reported that a "deficient vitamin C nutrition increases susceptibility to infection," and many others that animals dying from the effects of the poliomyelitis virus show a reduction of vitamin C in the tissues. Heaslip found a definite relationship between the severity of the infection and the level of vitamin C nutrition. It is consistent with accepted physiological action of vitamin C to expect and anti-edema effect in any given affected area. It is worthy of note that bacterial toxins can cause losses of from 50 to 85 per cent of the vitamin C normally contained in the adrenals.
Jungeblut's investigations seemed to justify the conclusion that vitamin C was the "antibiotic" that would destroy the virus organism. He stated that the prophylactic and therapeutic administration of synthetic or natural vitamin C had given evidence of having distinct therapeutic properties in experimental poliomyelitis, and that the proper injection dose was directly proportional to the speed of the infection and the stage at which the process had arrived.
Jungeblut stated in 1937 that the parental administration of natural vitamin C during its incubation period of poliomyelitis in monkeys is always followed by a distinct change in the severity of the disease; that after the fifth day of the disease distinctly larger doses are required. He realized, at that early date, that for a fast progressing infection such as results from the R. M. V. strain, very large doses—400 mg. crystalline C maximum in a 24-hour period—of vitamin C would be required; for the Aycock virus with its slower infection potential small amounts of the vitamin would suffice. Even with almost infinitesimal amounts—100 mg. ascorbic acid for each 24-hour period—he was able to demonstrate that the non-paralytic survivors in one series was six times as great as in the controls. In our work we shall speak of six, ten and 20 thousand mg. in a similar time period.
Harde et al. reported that diphtheria toxin is inactivated by vitamin C in vitro and to a lesser extent in vivo. I have confirmed this finding, indeed extended it. Diphtheria can be cured in man by the administration of massive frequent doses of hexuronic acid (vitamin C) given intravenously and/or intramuscularly. To the synthetic drug, by mouth, there is little response, even when 1000 to 2000 mg. is used every two hours. This cure in diphtheria is brought about in half the time required to remove the membrane and give negative smears by antitoxin. This membrane is removed by lysis when "C" is given, rather than by sloughing as results with the use of the antitoxin. An advantage of this form of therapy is that the danger of serum reaction is eliminated.
The only disadvantage of the ascorbic acid therapy is the inconvenience of the multiple injections. This concept of the action of vitamin C against certain toxins has led to treating other diseases producing exotoxins. For years it has been our knowledge that vitamin C in 500 to 1000 mg. doses injected I. M. would cure bacillary dysentery of the Shiga type. Children having 10 to 15 bloody stools per day have cleared in 48 hours under this schedule while at the same time reverting to normal feedings. This dual action of vitamin C against certain toxins and the virus organism becomes more intelligible with the work of Kligler, Warburg and others who believed that the detoxification effected by hexuronic acid is brought about by a direct combination of the vitamin with the toxin or virus, this followed by oxidation of the new compound which destroys both the virus or toxin and the vitamin. Borsook et al. decided that the main chemical action of ascorbic acid is as a powerful reducing agent, and the virus causing poliomyelitis is known to be susceptible to the oxidizing action of various agents. It is in point here to remark that vitamin C is an integral part of the oxidation-reduction system of the body, thus playing a definite part in natural resistance.
In the poliomyelitis epidemic in North Carolina in 1948, 60 cases of this disease came under our care. These patients presented all or almost all of these signs and symptoms: Fever of 101 to 104.6 degrees, headache, pain at the back of the eyes, conjunctivitis, scarlet throat; pain between the shoulders, the back of the neck, one or more extremity, the lumbar back; nausea, vomiting and constipation. In 15 of these cases the diagnosis was confirmed by lumbar puncture; the cell count ranging from 33 to 125. Eight had been in contact with a proven case; two of this group received spinal taps. Examination of the spinal fluid was not carried out in others for the reasons: (1) Flexner and Amoss had warned that "simple lumbar puncture attended with even very slight hemorrhage opens the way for the passage of the virus from the blood into the central nervous system and thus promotes infection." (2) A patient presenting all or almost all of the above signs and symptoms during an epidemic of poliomyelitis must be considered infected with this virus. (3) Routine lumbar puncture would have made it obligatory to report each case as diagnosed to the health authorities. This would have deprived myself of valuable clinical material and the patients of most valuable therapy, since they would have been removed to a receiving center in a nearby town.
Vitamin C in massive doses
The treatment employed was vitamin C in massive doses. It was given like any other antibiotic every two to four hours. The initial dose was 1000 to 2000 mg., depending on age. Children up to four years received the injections intramuscularly. Since laboratory facilitates for whole blood and urine determinations of the concentration of vitamin C were not available, the temperature curve was adopted as the guide for additional medication. The rectal temperature was recorded every two hours. No temperature response after the second hour was taken to indicate the second 1000 or 2000 mg. If there was a drop in fever after two hours, two more hours was allowed before the second dose. This schedule was followed for 24 hours. After this time the fever was consistently down, so the drug was given 1000 to 2000 mg. every six hours for the next 48 hours. All patients were clinically well after 72 hours. After three patients had a relapse the drug was continued for at least 48 hours longer—1000 to 2000 mg. every eight to 12 hours. Where spinal taps were performed, it was the rule to find a reversion of the fluid to normal after the second day of treatment.
For patients treated in the home the dose schedule was 2000 mg. by needle every six hours, supplemented by 1000 to 2000 mg. every two hours by mouth. The tablet was crushed and dissolved in fruit juice. All of the natural "C" in fruit juice is taken up by the body; this made us expect catalytic action from this medium. Rutin, 20 mg., was used with vitamin C by mouth in a few cases, instead of the fruit juice. Hawley and others have shown that vitamin C taken by mouth will show its peak of excretion in the urine in from four to six hours. Intravenous administration produces this peak in from one to three hours. By this route however, the concentration in the blood is raised so suddenly that a transitory overflow into the urine results before the tissues are saturated. Some authorities suggest that the subcutaneous method is the most conservative in terms of vitamin C loss but this factor is overwhelmingly neutralized by the factor of pain inflicted.
Two patients in this series of 60 regurgitated fluid through the nose. This was interpreted as representing the dangerous bulbar type. For a patient in this category postural drainage, oxygen administration, in some cases tracheotomy, needs to be instituted, until the vitamin C has had sufficient time to work—in our experience 36 hours. Failure to recognize this factor might sacrifice the chance of recovery. With these precautions taken, every patient of this series recovered uneventfully within three to five days.
In the treatment of other types of virus infections the same "fluid" dose schedule was adopted. In herpes zoster 2000 to 3000 mg. of vitamin C was given every 12 hours, this supplemented by 3 000 mg. in fruit juice by mouth every two hours. Eight cases were treated in this series, all of adults. Seven experienced cessation of pain within two hours of the first injection and remained so without the use of any other analgesic medication. Seven of these cases showed drying of the vesicles within 24 hours and were clear of lesions within 72 hours. They received from five to seven injections.
One patient; a diabetic, stated that she was always conscious of an uncomfortable feeling, but that it was not an actual pain. Although nine-tenths of the vesicles cleared in the usual 72-hour period, she was given 14 injections, the last seven of only 1000 mg. This extra therapy was given because of a small ulceration, an inch in diameter, secondarily infected by rupture of the vesicles by a corset stave prior to the first visit. Vitamin C apparently had no effect on this lesion, which was healed in two weeks under compound tincture of benzoin locally and penicillin and sulfadiazine by mouth. (The patient objected to taking penicillin by needle.)
One of the patients, a man of 65, came to the office doubled up with abdominal pain and with a history of having taken opiates for the preceding 36 hours. He gave the impression of having an acute surgical condition. A massive array of vesicles extended from the dorsal nerve roots to the umbilicus, a hand's breadth wide. He was given 3000 mg. of vitamin C intravenously and directed to return to the office in four to five hours. It was difficult to convince him that his abdominal pain was the result of his having "shingles." He returned in four hours completely free of pain. He was given an additional 2000 mg. of vitamin C, and following the schedule given above he recovered completely in three days.
In herpes simplex it is important to continue the treatment for at least 72 hours. We have seen "fever blisters" that appeared healed after two injections recur when therapy was discontinued after 24 hours. Vitamin C in a strength of 1000 mg. per 10 c.c. of buffered solution gave no response when applied locally. This was true no matter how often the applications were made. In several cases 10 mg. of riboflavin by mouth t.i.d. in conjunction with the vitamin C injections appeared to cause faster healing.
Chickenpox gave equally good response, the vesicles responding in the same manner as did those of herpes. These vesicles were crusted after the first 24 hours, and the patient well in three to four cays. We interpreted this similarity of response in these three diseases to suggest that the viruses responsible were closely related to one another.
Many cases of influenza were treated with vitamin C. The size of the dose and the number of Injections required were in direct proportion to the fever curve and to the duration of the illness. Forcing of fruit juice was always recommended, because of the frequency and ease of reinfection during certain periods of the year.
The response of virus encephalitis to ascorbic acid therapy was dramatic. Six cases of virus encephalitis were treated and cured with vitamin C injections. Two cases were associated with virus pneumonia; one followed chickenpox, one mumps, one measles and one a combination of measles and mumps. In the case that followed the measles-mumps complex, definite evidence was found to confirm the belief that massive, frequent injections are necessary in treating virus infections with vitamin C.
This lad of eight years was first seen with a temperature of 104 degrees. He was lethargic, very irritable when molested. His mother said he had gradually developed his present clinical picture over the preceding four or five days. His first symptom was anorexia which became complete 36 hours before his first examination. He next complained of a generalized headache, later be became stuporous. Although very athletic and active, he voluntarily took to his bed. He was given 2000 mg. of vitamin C intravenously and allowed to return home because there were no available hospital accommodations. His mother was asked to make an hourly memorandum of his conduct until his visit set for the following day. Seen 18 hours after the initial injection of vitamin C, the memorandum revealed a quick response to the antibiotic — after two hours he asked for food and ate a hearty supper, then played about the house as usual and then, for several hours, he appeared to have completely recovered. Six hours following the initial injection, he began to revert to the condition of his first visit. When seen the second time temperature was 101.6 degrees, he was sleepy but he would respond to questions. The rude irritability shown prior to the first injection was strikingly absent. A second injection of 2000 mg. vitamin C was given intravenously and 1000 mg. of "C" prescribed every two hours by mouth. The next day he was fever and symptom-free. As a precautionary measure a third 2000 mg. was given with direction to continue the drug by mouth for at least 48 hours. He has remained well since.
A lad of 12 years had generalized headache a week after having mumps, this followed by malaise, and in 12 hours a lethargic state and a fever of 105 degrees. Admitted to hospital he was given 2000 mg. of vitamin C then, and 1000 mg. every two hours. Following the third injection he was sitting up in bed, laughing, talking, begging for food and completely without pain. He was discharged 24 hours following admission clinically well. Since relapses do occur if the drug is discontinued too soon, he was given 2000 mg. of vitamin C every 12 hours for two additional days.
The use of vitamin C in measles proved to be a medical curiosity. During an epidemic vitamin C was used prophylactically and all those who received as much as 1000 mg. every six hours, by vein or muscle, were protected from the virus. Given by mouth, 1000 mg. in fruit juice every two hours was not protective unless it was given around the clock. It was further found that 1000 mg. by mouth, four to six times each day, would modify the attack; with the appearance of Koplik's spots and fever, if the administration was increased to 12 doses each 24 hours, all signs and symptoms would disappear in 48 hours. If the drug was discontinued or reduced to three or four doses each 24 hours following the disappearance of Koplik's spots, within another 48-hour period the fever, the conjunctivitis and Koplik's spots would be back.
It was our privilege to observe this picture over and over in two little volunteer girls for 30 days. These "research helpers" were my own little daughters. The measles virus was eventually destroyed in this instance by continuing 12,000 mg. by mouth each 24 hours for four days. We interpreted this result to indicate that on withdrawing the drug with the cessation of signs and symptoms, a small quantity of the virus remained, which after another incubation period produced anew the first stage of measles; when the drug was continued beyond the clearing stage the virus was destroyed in toto. No case of post-measles bronchopneumonia was seen. The "measles-cough" of measles bronchitis was over with after three or four 1000 mg. injections of "C" at 6-hour intervals. This was true even when other medications well above the calculated dose range for cough had had no effect. Whenever a patient presented a mixed-virus infection, such as receding mumps and developing measles, it was found that double the calculated dose of vitamin C was necessary to obtain the usual results.
Of mumps, 33 cases were treated with ascorbic acid. When vitamin C was given at the peak of the infection the fever was gone within 24 hours, the pain within 36 hours, the swelling in 48 to 72 hours. Two cases were complicated with orchitis. A young man of 23 years developed bilateral orchitis one Friday morning, by seven o'clock that night he was in severe pain, had a fever of 105" and was nursing testicles the size of tennis balls. Vitamin C was started at this time—1000 mg. every two hours, intravenously. The pain began to subside following the first injection and ceased in 12 hours. There was no fever after 36 hours. The patient was out of bed feeling his old self after 60 hours. He had received 25,000 mg. of "C" in this 60-hour period. An experiment involving three cousins: One, a boy of seven, had the old routine of bed rest, aspirin, and warm camphor oil applications and iodex to the swollen glands. This child had a rough time for a week. A second boy, aged 11, was allowed to develop mumps to the point of maximum swelling without any therapy, then given vitamin C, 1000 mg. intramuscularly, every two to four hours. This lad was entirely well in 48 hours. To the third patient, a girl of 9, vitamin C was given on the up curve when the swellings were 60 per cent of the expected, and the temperature recorded at 102.3 degrees. The dose was 1000 mg. of vitamin C given intravenously every four hours. This child was well and remained so from the third day of treatment.
Further studies on virus pneumonia showed that the clinical response was better when vitamin C was given to these patients according to the dose schedule outlined for poliomyelitis. Where pneumonitis was demonstrated, the clearing of the chest film was parallel with the clinical recovery. In cases of consolidation of entire lobes the x-ray clearing lagged days behind the clinical response. In these cases 1000 mg. of "C" should be given every 12 hours for at least a week after the patient is apparently well. There was no change in the results as given in a previous paper; the patients were well in the third day of treatment.
Vitamin C as an antibiotic
In using vitamin C as an antibiotic no factor of toxicity need be considered. To confirm this observation 200 consecutive hospital patients were given ascorbic acid, 500 to 1000 mg. every four to six hours, for five to ten days. One volunteer received 100,000 mg. in a 12-day period. It must be remembered that 90 per cent of these patients did not have a virus infection to assist in destroying the vitamin. In no instance did examination of the blood or urine indicate any toxic reaction, and at no time were there any clinical manifestations of a reaction to the drug. When vitamin C was given by mouth one per cent of these patients vomited shortly after taking the drug. In half of these cases the vomiting was controlled by increasing the carbohydrate content of the mixture. This reaction was not interpreted as representing a toxic manifestation; rather it was thought to be due to a hypersensitive gastric mucosa. The dose was reduced from 1000 to 100 mg. in young children showing this complex; vomiting occurred as before. However, in these same patients administration of massive, frequent doses of vitamin C by needle affected a cure of the infection without causing vomiting.
From a review of the literature one can safely state that in all instances of experimental work with ascorbic acid on the virus organism the amount of virus used was beyond the range of the administered dose of this vitamin. No one would expect to relieve kidney colic with a five-grain aspirin tablet; by the same logic we cannot hope to destroy the virus organism with doses of vitamin C of 10 to 400 mg. The results which we have reported in virus diseases using vitamin C as the antibiotic may seem fantastic. These results, however, are no different from the results we see when administering the sulfa, or the mold-derived drugs against many other kinds of infections. In these latter instances we expect and usually get 48- to 72-hour cures; it is laying no claim to miracle-working then, when we say that many virus infections can be cleared within a similar time limit.
(1) Source: The Treatment of Poliomyelitis and Other Virus Diseases with Vitamin C (1949) (accessed in 2014; link no longer working) The formatting into sections with headers is ours. (Alternative link to the source; 2021) (Digitized in PDF format)
Published on May 8th, 2014
© Format Copyright 2014 - 2021 by The M+G+R Foundation. All rights reserved. However, you may freely reproduce and distribute this document as long as: (1) Appropriate credit is given as to its source; (2) No changes are made in the text without prior written consent; and (3) No charge is made for it.
The M+G+R Foundation
About Us || Frequently Asked Questions || Disclaimer
Successful High-Dose Vitamin C Treatment of Patients with Serious and Critical COVID-19 Infection
Vitamin C Treatment of COVID-19: Case Reports
Index of Documents Regarding Covid-19 / Coronavirus
Vitamin C Treatment of COVID-19: Case Reports
Index of Documents Regarding Covid-19 / Coronavirus
PAGE of INTRODUCTION to DOMAIN
HOME PAGE - Español
HOME PAGE - Portugues
Back Up HOME PAGE
Our Research Department
Please Note: If the above dated image does not appear on this document, it means that you are not viewing the original document from our servers. Should you have reason to doubt the authenticity of the document, we recommend that you access our server again and click on the "Refresh" or "Reload" button of your Browser to view the original document.
If you wish to contact The M+G+R Foundation, please access our Contact Page and follow the instructions.